Korro Bio Inc
NASDAQ:KRRO

Watchlist Manager
Korro Bio Inc Logo
Korro Bio Inc
NASDAQ:KRRO
Watchlist
Price: 52.31 USD 3.34% Market Closed
Market Cap: 486.5m USD
Have any thoughts about
Korro Bio Inc?
Write Note

Intrinsic Value

KRRO's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one KRRO stock under the Base Case scenario is 17.87 USD. Compared to the current market price of 52.31 USD, Korro Bio Inc is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRRO Intrinsic Value
17.87 USD
Overvaluation 66%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Korro Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KRRO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KRRO?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Korro Bio Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Korro Bio Inc

Provide an overview of the primary business activities
of Korro Bio Inc.

What unique competitive advantages
does Korro Bio Inc hold over its rivals?

What risks and challenges
does Korro Bio Inc face in the near future?

Has there been any significant insider trading activity
in Korro Bio Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Korro Bio Inc.

Provide P/S
for Korro Bio Inc.

Provide P/E
for Korro Bio Inc.

Provide P/OCF
for Korro Bio Inc.

Provide P/FCFE
for Korro Bio Inc.

Provide P/B
for Korro Bio Inc.

Provide EV/S
for Korro Bio Inc.

Provide EV/GP
for Korro Bio Inc.

Provide EV/EBITDA
for Korro Bio Inc.

Provide EV/EBIT
for Korro Bio Inc.

Provide EV/OCF
for Korro Bio Inc.

Provide EV/FCFF
for Korro Bio Inc.

Provide EV/IC
for Korro Bio Inc.

Show me price targets
for Korro Bio Inc made by professional analysts.

What are the Revenue projections
for Korro Bio Inc?

How accurate were the past Revenue estimates
for Korro Bio Inc?

What are the Net Income projections
for Korro Bio Inc?

How accurate were the past Net Income estimates
for Korro Bio Inc?

What are the EPS projections
for Korro Bio Inc?

How accurate were the past EPS estimates
for Korro Bio Inc?

What are the EBIT projections
for Korro Bio Inc?

How accurate were the past EBIT estimates
for Korro Bio Inc?

Compare the revenue forecasts
for Korro Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Korro Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Korro Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Korro Bio Inc compared to its peers.

Compare the P/E ratios
of Korro Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Korro Bio Inc with its peers.

Analyze the financial leverage
of Korro Bio Inc compared to its main competitors.

Show all profitability ratios
for Korro Bio Inc.

Provide ROE
for Korro Bio Inc.

Provide ROA
for Korro Bio Inc.

Provide ROIC
for Korro Bio Inc.

Provide ROCE
for Korro Bio Inc.

Provide Gross Margin
for Korro Bio Inc.

Provide Operating Margin
for Korro Bio Inc.

Provide Net Margin
for Korro Bio Inc.

Provide FCF Margin
for Korro Bio Inc.

Show all solvency ratios
for Korro Bio Inc.

Provide D/E Ratio
for Korro Bio Inc.

Provide D/A Ratio
for Korro Bio Inc.

Provide Interest Coverage Ratio
for Korro Bio Inc.

Provide Altman Z-Score Ratio
for Korro Bio Inc.

Provide Quick Ratio
for Korro Bio Inc.

Provide Current Ratio
for Korro Bio Inc.

Provide Cash Ratio
for Korro Bio Inc.

What is the historical Revenue growth
over the last 5 years for Korro Bio Inc?

What is the historical Net Income growth
over the last 5 years for Korro Bio Inc?

What is the current Free Cash Flow
of Korro Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Korro Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Korro Bio Inc

Current Assets 152.8m
Cash & Short-Term Investments 137m
Receivables 10m
Other Current Assets 5.8m
Non-Current Assets 90.8m
Long-Term Investments 32.1m
PP&E 53.1m
Other Non-Current Assets 5.5m
Current Liabilities 13.6m
Accounts Payable 6m
Accrued Liabilities 4.9m
Other Current Liabilities 2.8m
Non-Current Liabilities 50.3m
Other Non-Current Liabilities 50.3m
Efficiency

Earnings Waterfall
Korro Bio Inc

Revenue
0 USD
Operating Expenses
-108.4m USD
Operating Income
-108.4m USD
Other Expenses
6.8m USD
Net Income
-101.6m USD

Free Cash Flow Analysis
Korro Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KRRO Profitability Score
Profitability Due Diligence

Korro Bio Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

Korro Bio Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

KRRO Solvency Score
Solvency Due Diligence

Korro Bio Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
60/100
Solvency
Score

Korro Bio Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRRO Price Targets Summary
Korro Bio Inc

Wall Street analysts forecast KRRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRRO is 136.51 USD with a low forecast of 106.05 USD and a high forecast of 189 USD.

Lowest
Price Target
106.05 USD
103% Upside
Average
Price Target
136.51 USD
161% Upside
Highest
Price Target
189 USD
261% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KRRO?

Click here to dive deeper.

Dividends

Korro Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KRRO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

KRRO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Korro Bio Inc Logo
Korro Bio Inc

Country

United States of America

Industry

Biotechnology

Market Cap

516.5m USD

Dividend Yield

0%

Description

Korro Bio Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 48 full-time employees. The company went IPO on 2019-10-03. Korro Bio, Inc. is a biopharmaceutical company. The firm discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The firm is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Its Oligonucleotide Promoted Editing of RNA (OPERA) is a foundational platform for RNA editing, which is designed to edit RNA in vivo by delivering an oligonucleotide guide that can target specific RNA sequences. OPERA co-opts the cell’s natural process with its synthetic oligo and catalyzes a single base change to modify protein sequence and function without the need to permanently modify one’s genome. The firm's focus areas include the liver and central nervous system (CNS).

Contact

MASSACHUSETTS
Cambridge
One Kendall Square. Building 600-700, Suite 6-401
+16174681900
www.korrobio.com

IPO

2019-10-03

Employees

48

Officers

Co-Founder & Independent Chairman of the Board
Mr. Nessan Bermingham Ph.D.
CEO, President & Director
Mr. Ram Aiyar MBA, Ph.D.
Co-Founder & Independent Director
Dr. Jean-Francois Formela M.D., MBA
Chief Financial Officer
Mr. Vineet Agarwal M.B.A.
Co-Founder & Advisor
Dr. Joshua Rosenthal Ph.D.
Chief Operating Officer
Mr. Todd Chappell M.B.A.
Show More
Senior VP & General Counsel
Mr. Jeffrey M. Cerio J.D., Pharm.D.
Senior VP and Head of People & Culture
Ms. Stephanie Engels
VP & Head of CNS biology
Mr. Marco A. Passini Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one KRRO stock?

The intrinsic value of one KRRO stock under the Base Case scenario is 17.87 USD.

Is KRRO stock undervalued or overvalued?

Compared to the current market price of 52.31 USD, Korro Bio Inc is Overvalued by 66%.

Back to Top